SafeTaper vs RxDown
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
SafeTaper
This app serves as a personalized care hub for users on a tapering journey. It offers a secure and user-friendly platform to guide and support individuals through their treatment process.
- Personalized care hub
- Guided tapering journey
- Secure platform
- User-friendly interface
- Patient support
Read full descriptionHide full description
SafeTaper Patient Portal: Your Personalized Care Hub A secure, user-friendly app designed to guide and support you on your tapering journey.
RxDown
This app helps you track medication withdrawal by recording your experiences through voice journaling. It analyzes dose changes, identifies withdrawal patterns, and generates reports for your doctor.
- AI Voice Journaling
- Receptor Occupancy Visualization
- Guideline-Based Reduction Plans
- Benzodiazepine & Z-Drug Education
- Flexible Dosing Units
- Sleep Import from Apple Health
- Visual Trend Analysis
- Doctor Report Generation
Read full descriptionHide full description
Track your medication withdrawal journey with AI-powered voice journaling. RxDown records how dose changes affect your body, spots withdrawal patterns, helps plan your next reduction step, and shares clear data with your doctor. Coming off medication is hard: you can't easily recall how you felt two weeks ago, or whether a small dose cut disrupted your sleep. RxDown turns spoken check-ins into structured, searchable health records that bridge your daily experience and your medical appointments. Whether you are weaning off antidepressants, benzodiazepines, opioids, sleeping pills, or other long-term prescriptions, RxDown helps you manage withdrawal symptoms, track holds and reinstatements, and communicate clearly with your healthcare provider. KEY FEATURES AI Voice Journaling Don't feel like typing? Talk. The AI (powered by Gemini) captures dose, sleep, symptoms, mood, and physical sensations from your spoken log. Review and edit every entry before saving. NEW: Receptor Occupancy, Made Visible See why the last milligrams matter. RxDown plots estimated receptor occupancy alongside your dose curve, based on the hyperbolic model described by Horowitz and the Maudsley Deprescribing Guidelines, and offers an occupancy-based reduction strategy. Guideline-Based Reduction Plans Build schedules grounded in the Maudsley Deprescribing Guidelines, the Ashton Manual, and Royal College of Psychiatrists references. Hold and reinstate are first-class states, not failures — pause when you need to, step back when symptoms flare. NEW: Benzodiazepine & Z-Drug Education Ashton-based guidance with diazepam-equivalence reference, plus formulation tips for the small doses at the end of a reduction — liquids, compounded preparations, and careful dispersion. NEW: Flexible Dosing Units Log tablets, milligrams, or liquid millilitres — a unit-first picker makes tiny doses practical to record accurately. NEW: Sleep Import from Apple Health Connect Apple Health and RxDown imports your sleep automatically, so dose changes and sleep quality line up in one timeline. Visual Trend Analysis See dose, sleep, and stability together through four lenses — dose curve, stability score, sleep pattern, and symptom timeline — and spot whether a reduction affects sleep or mood days later. AI Symptom Analysis & Suggestions The AI highlights potential links between dose changes and symptom flare-ups, and suggests a personalized next step — based on your logs and chosen guideline — to discuss with your prescribing doctor. NEW: Doctor Report Generate a clinician-ready report in SBAR format with trend charts and a plain-language AI narrative, plus clean CSV and PDF exports of your history, plans, logs, and journal. Bring it to your next appointment. Privacy & Data Security Your diary stays on your device. RxDown has no account and cannot see your logs. When you use an AI feature, only the content for that request is processed, and it is not used to train models. We never sell your personal health data. WHO USES RXDOWN RxDown is designed for adults working with a doctor to reduce or come off medication — often called tapering or deprescribing. It helps anyone with withdrawal symptoms track triggers and bring organized data to consultations. IMPORTANT DISCLAIMERS This app is intended for adults aged 18 and older. RxDown is a data tracking and journaling tool. It does not provide medical advice, diagnosis, or treatment. AI-generated insights, charts, and schedule suggestions are for informational purposes only. Never stop taking medication or change your dose based solely on data from this app. Reducing medication should always be done under the supervision of a qualified healthcare professional. If you experience severe withdrawal symptoms or a medical emergency, contact your doctor or emergency services immediately. RxTaper is now RxDown — same app, your data is untouched. Terms of Use (EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/
Screenshots
Verdict
SafeTaper and RxDown both sit at 4.0 stars, but that hides the real split: 100% of RxDown's written reviews are positive against 50% of SafeTaper's. RxDown also leads on update cadence (weekly vs every 3 weeks). SafeTaper's advantage is in-app purchases (none vs 5) and ratings volume (4 vs 1). On price, rating, ads and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. RxDown sells 5 in-app purchases, starting at $0.59 per month. SafeTaper asks for nothing beyond the download.
On the App Store both sit at effectively the same score — 4.0 for SafeTaper against 4.0 for RxDown. Both are backed by a comparable volume of ratings — 4 and 1 respectively. Written reviews are what separate them: 50% of SafeTaper's written reviews are positive against 100% of RxDown's.
SafeTaper ships an update every 3 weeks, RxDown weekly. The most recent releases landed on October 30, 2026 and November 7, 2026 respectively.
| Parameter | SafeTaper | RxDown |
|---|---|---|
| Price | Free | Free |
| Rating | 4.0 (4 ratings) | 4.0 (1 ratings) |
| Positive reviews | 50.0% of reviews | 100.0% of reviews — better |
| Number of ratings | 4 — better | 1 |
| Update frequency | Every 3 weeks | Weekly — better |
| Ads | No | No |
| In-app purchases | No — better | Yes |
| Monetization | Free — better | Free with in-app purchases |
| Devices | iPhone, iPad — better | iPhone |
| Requires iOS | 17.0 | 16.0 — better |
| Further details — not scored | ||
| Size | 69 MB | 89 MB |
| Age rating | 17+ | 17+ |
| Developer | SafeTaper Inc. | CHIH YU LIN |
Customer experience
SafeTaper
RxDown
In-app purchases
SafeTaper
No in-app purchases
RxDown
- Premium Monthly$0.591 Month
- Plus Monthly$1.491 Month
- Pro Monthly$2.991 Month
Show 2 moreShow fewer
- Plus Yearly$11.991 Year
- Pro Yearly$23.991 Year





